Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pfizer Partnership Philosophy Relies On One Manager, Five “C”s

Executive Summary

Pfizer relies on one manager to oversee all aspects of an R&D agreement to help ensure that the goals identified in creating the partnership translate into day-to-day practice

You may also be interested in...

Pfizer Recognizes “Dark Side” Of Scale In R&D; No Sales Force Cuts Planned

Pfizer relies on competition among research teams to help ensure that its vast R&D resources do not diminish the entrepreneurial spirit within the organization, CFO David Shedlarz told the Merrill Lynch pharmaceutical and biotechnology conference Feb. 5 in New York City

Pfizer/Esperion Deal Reunites Lipitor Team; $1.3 Bil. Buys Two HDL Agents

Pfizer's $1.3 bil. acquisition of Esperion will reunite the Lipitor research team and give Pfizer two more chances to develop a novel mechanism anti-atherosclerotic agent

Pfizer Expects Pliant Partners: Deferring To Pfizer Skills And Strengths

Pfizer expects its partners to defer to Pfizer in areas where it has a clear advantage in established skills and size, rather than push the joint arrangements as a way for the smaller firm to develop new functions

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts